Ads
related to: new rheumatoid arthritis infusion drugsdoconsumer.com has been visited by 100K+ users in the past month
helperwizard.com has been visited by 10K+ users in the past month
assistantmagic.com has been visited by 10K+ users in the past month
explorefrog.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
rheumatoid arthritis, Crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic disease of the newborn: Adecatumumab [9] mab: human: EpCAM: prostate and breast cancer: Aducanumab [10] Aduhelm: mab: human: Amyloid beta: Y [11] Alzheimer's disease: Afasevikumab [12] mab: human: IL-17A ...
Despite widespread expectations that the FDA would approve baricitinib for rheumatoid arthritis, [24] in April 2017, the FDA issued a rejection, citing concerns about dosing and safety. [25] [26] In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis. [9] [12] [10]
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases.This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. [23]
Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. [1] [3] It is a modified antibody. [1] [3] Abatacept is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4.
Shares of Antares Pharma , a developer of auto injectors and topical gel treatments, rallied on Monday after the company announced that the Food and Drug Administration had approved its Otrexup ...
Ads
related to: new rheumatoid arthritis infusion drugsdoconsumer.com has been visited by 100K+ users in the past month
helperwizard.com has been visited by 10K+ users in the past month
assistantmagic.com has been visited by 10K+ users in the past month
explorefrog.com has been visited by 10K+ users in the past month